Eight Months EndedDecember 31,
2025
2024
Product revenue, net
$
49,078
—
Total operating expenses
161,115
117,030
Operating loss
(112,037)
(117,030)
Total other income
1,480
6,576
Loss before income tax (benefit) expense
(110,557)
(110,454)
Income tax (benefit) expense
(1,033)
Net loss
(109,524)
Weighted average shares outstanding-basic and diluted
53,870,007
47,958,970
Net loss per share
Basic and diluted
(2.03)
(2.30)
Schedule of transition period comparative data.
No definition available.
Transition period comparative data.